AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
56 hedge funds and large institutions have $541M invested in Akcea Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
-1
Holders Change %
-1.75%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
23
Reduced
18
Closed
9
Calls
$3.19M
Puts
$2.42M
Net Calls
+$774K
Net Calls Change
+$537K
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$295M |
| 2 |
BG
2
Bellevue Group
Kuesnacht,
Switzerland
|
$8.99M |
| 3 |
AA
3
ALPS Advisors
Denver,
Colorado
|
$2.93M |
| 4 |
4
BlackRock
New York
|
$45.1M |
| 5 |
BB
5
BB Biotech
Schaffhausen,
Switzerland
|
$58.9M |
